Cook unveils CookBiodesign.com

Share this article:
Cook Medical launched a third website for physicians and consumers, this time focusing on a suite of tissue repair products.

The site, CookBiodesign.com, provides resources for physicians on specific medical procedures related to tissue repair, featuring animation and video, billing and coding info, PubMed links, and post-op guides for patients, among other things. Docs can also sign up for newsletter emails, and contact Cook reps directly from the sight. For patients, the site offers testimonial video and information about specific tissue conditions and treatments.

Andy Cron, VP of Cook's surgery division, said the site helps to present information to physicians that can be difficult to communicate through a sales rep.

“It takes time to educate physicians…and it's very difficult to find time with them,” said Cron.

Cook launched the site during the American College of Surgeons meeting (Oct 11-15), and is promoting it through optimized keywords and direct mail to over 30,000 surgeons. CookBiodesign.com was built through a partnership with Digital Influence Group, which also worked on CookARTLab.com and MensHealthPD.com. Cron said the company is considering social media activities for the site, including Twitter.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...